01 September 2005
Effective dose of 5-fluorouracil for myringotomy in rats.
Hakan Cincik, Hakan Cincik, Omer Saglam, Engin Cekin, Sükrü Yildirim, Ethem PoyrazogluMed Sci Monit 2005; 11(9): BR330-334 :: ID: 428444
Abstract
Background: The purpose of this study is to compare the effects of twodifferent doses of 5-fluorouracil (5-FU) on closure rates and histopathological findings in myringotomyto those of simple myringotomy with saline application. Material/Methods: 36 rats were divided into twostudy groups and a control group of 12 rats each. After bilateral myringotomy, we applied 5-FU 50 mg/mlin group A, 10 mg/ml in group B and saline in the control group for 10 minutes. Examination was madeby otoendoscopy on days 1, 3, 5, 7, 10, 15, 20, 25. After the follow up examination, two rats from eachgroup were randomly sacrificed on days 7, 15, 25 and 35. Both tympanic membranes were investigated forfibrosis and inflammation by light microscopy. Results: Most of the tympanic membranes from group B andthe control group healed on the 10(th) day, but 16 myringotomies were patent in group A; by the 25(th)day, all myringotomies in all three groups were completely healed. The mean healing time was 14.62 days,10.20 days and 10.40 days respectively in groups A, B and control. Fibrosis and inflammation were lessin group A than in group B and the controls. Conclusions: 5-FU at a concentration of 50 mg/mL is effectivein prolonging the patency of myringotomies in rat tympanic membranes, while a concentration of 10 mg/mLhas no greater effect than a simple myringotomy procedure with saline application.
Keywords: Antimetabolites - administration & dosage, Dose-Response Relationship, Drug, Fibrosis, Fluorouracil - administration & dosage, Inflammation - prevention & control, Middle Ear Ventilation - methods, Otitis Media with Effusion - surgery, Tympanic Membrane - surgery, Wound Healing - drug effects
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952